Pilot Study Evaluating the Efficacy of a Topical PDE4 Inhibitor for Morphea
Phase of Trial: Phase II
Latest Information Update: 19 Sep 2018
At a glance
- Drugs Crisaborole (Primary)
- Indications Circumscribed scleroderma
- Focus Proof of concept; Therapeutic Use
- 11 Sep 2018 Status changed from not yet recruiting to recruiting.
- 02 Jul 2018 Planned End Date changed from 1 Jun 2019 to 1 Dec 2019.
- 02 Jul 2018 Planned primary completion date changed from 1 Jun 2019 to 1 Dec 2019.